Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
LFLifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR)

NASDAQ · Currency in USD
$6.40 ▲ +0.03 (+0.47%)
At close: Oct 23, 4:00 PM ET. Market closed.
$6.48 ▲ +0.08 (+1.20%)
After hours: Oct 23, 7:54 PM ET

Summary

Previous Close
$6.37
Open
$6.36
Day's Range
$6.36 – $6.40
52 Week Range
$3.63 – $8.98
Volume
224,036
Avg. Volume
307,334
Market Cap
$242.60M
Beta (5Y Monthly)
0.98
PE Ratio (TTM)
--
EPS (TTM)
-$0.99
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$6.39

Profile: Lifecore Biomedical, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
382
CEO
Paul Josephs

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate -$0.30 · Revenue est. $25.57M
DateEst.Actual
Aug 5, 2026-$0.19-$0.19Beat
May 6, 2026-$0.24-$0.43Miss
Mar 9, 2026-$0.18-$0.19Miss
Nov 6, 2025-$0.30-$0.29Beat
Aug 7, 2025-$0.09-$0.10Miss
Apr 3, 2025-$0.14-$0.47Miss

Analyst view

Consensus price target
$6.39 ▼ -0.2%
Range $6.28 – $6.50
Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on LFCR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.